Steven M. Paul
- Behavioral Neuroscience top 0.5%
- Biological Psychiatry top 1%
-
- Neurotransmitter Receptor Influence on Behavior 9
- Neuroscience and Neuropharmacology Research 7
- Neuropeptides and Animal Physiology 4
- Nephrology top 1%
- Dialysis and Renal Disease Management 5
- Transplantation top 2%
-
- Receptor Mechanisms and Signaling 10
-
- Neuroendocrine regulation and behavior 6
-
- Cancer survivorship and care 5
-
- Schizophrenia research and treatment 4
- Co-authors
- Perry H. MooreR. H. PurdyA. Leslie MorrowPatricia PainterJacqueline N. CrawleySusan CareyLaurie CarlsonJeffrey Myll
- Journals
- European Journal of Pharmacology (6 papers)Journal of Neurochemistry (4 papers)Oncology nursing forum (3 papers)
- Partner nations
- United StatesCzechiaGermany
In The Last Decade
Steven M. Paul
63 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Behavioral Neuroscience 943
- Biological Psychiatry 361
- Cellular and Molecular Neuroscience 1.4k
- Nephrology 534
- Transplantation 163
Countries citing papers authored by Steven M. Paul
This map shows the geographic impact of Steven M. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Paul more than expected).
Fields of papers citing papers by Steven M. Paul
This network shows the impact of papers produced by Steven M. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Paul. The network helps show where Steven M. Paul may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steven M. Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trialbreakdown → | 2023 | 104 |
| 5 | 2022 | 5 | |
| 6 | 2009 | 119 | |
| 7 | 2006 | 127 | |
| 8 | 2005 | 55 | |
| 9 | 2004 | 357 | |
| 10 | 2002 | 58 | |
| 11 | 2001 | 116 | |
| 12 | 2000 | 128 | |
| 13 | 1995 | 19 | |
| 14 | 1994 | 48 | |
| 15 | 1994 | 50 | |
| 16 | 1993 | 104 | |
| 17 | 1993 | 61 | |
| 18 | 1992 | 4 | |
| 19 | 1989 | 5 | |
| 20 | 1988 | 10 |
About Steven M. Paul
Steven M. Paul is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience and Nephrology, having authored 64 papers that have together received 4.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers), Neuroscience and Neuropharmacology Research (7 papers), Neuroendocrine regulation and behavior (6 papers), Dialysis and Renal Disease Management (5 papers), Cancer survivorship and care (5 papers), Neuropeptides and Animal Physiology (4 papers) and Schizophrenia research and treatment (4 papers). The work is most often cited by research in Behavioral Neuroscience (943 citations), Biological Psychiatry (361 citations) and Cellular and Molecular Neuroscience (1.4k citations). Steven M. Paul has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include Perry H. Moore, R. H. Purdy, A. Leslie Morrow, Patricia Painter, Jacqueline N. Crawley, Susan Carey, Laurie Carlson, Jeffrey Myll, Nancy L. Ascher and John R. Glowa. Their work appears in journals such as European Journal of Pharmacology, Journal of Neurochemistry, Oncology nursing forum, Nursing Research and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.